FOLH1 and neoplasm: Kelly et al. [17] reported the 3p-C-DEPA containing [68Ga]Ga-EuK-107, which showed good tumor targeting in vivo in a proof-of-concept microPET/CT study in LNCaP tumor xenograft mice, with similar uptake compared to the commercially used [68Ga]Ga-DKFZ-PSMA-11 ([68Ga]Ga-PSMA-11, Gallium (68Ga) gozetotide).